A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy Volunteers

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 29, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Ocular Pain

Interventions

DRUG

BL1332 ophthalmic solution

Both arms taken four times a day for 1 day

DRUG

BL1332 ophthalmic vehicle

Both arms taken four times a day for 1 day

Trial Locations (1)

Site 101, Fair Lawn

All Listed Sponsors

lead

Bausch & Lomb Incorporated

INDUSTRY